Spotlight on Glycolysis: A New Target for Cord Blood Expansion.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 29859169.
- Also identified by DOI 10.1016/j.stem.2018.04.023.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Umbilical cord blood (UCB) is a highly valuable but low-quantity source of hematopoietic stem cells (HSCs) for life-saving transplantations. Recently in Nature Medicine, Guo et al. (2018) found that antagonism of a glycolysis-blocking pathway enhances ex vivo expansion of long-term HSCs from human UCB.
Medical subject headings
- Fetal Blood
- Hematopoietic Stem Cell Transplantation